Osteoarthritis Trial, Recruiting NCT07537153 Sponsor: Northwestern University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07537153
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 40 and 80 years old
  • People with mild-to-moderate knee osteoarthritis confirmed by X-ray results showing a specific severity level (Kellgren-Lawrence grade 2 or 3)
  • People who report their knee pain as at least 5 out of 10 on a standard pain scale
  • People who have already tried conservative treatments, such as pain medications, for at least 3 months without enough relief
  • People who are able to understand and sign a consent form agreeing to take part
  • People who are able to attend follow-up appointments as scheduled by the trial
  • People who are able to follow the recovery and care instructions after the procedure

Who may not be able to join:

  • People with a history of rheumatoid arthritis
  • People whose kidneys do not function well enough to safely receive the dye used in imaging procedures (confirm with trial site)
  • People with a bleeding or clotting disorder that cannot be treated or reversed
  • People who have previously had a knee replacement on the knee being considered for the trial
  • People with a current infection in the knee joint
  • People whose X-ray results show the mildest or most severe level of osteoarthritis (Kellgren-Lawrence grade 1 or 4)
  • People with serious narrowing of the arteries that causes leg pain when walking or reduced pulse in the legs
  • People with a life expectancy of less than 6 months
  • People with arthritis caused by an infection
  • People who have had a severe allergic reaction (anaphylaxis) to the type of dye used in imaging procedures
  • People who are pregnant or planning to become pregnant within three months of the procedure
  • People who are currently involved in a legal claim or workers' compensation case related to their condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert Lewandowski, MD, Northwestern University

Phone: 312-695-9121

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 July 2026
Est. completion
10 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient safety endpoints; Objective clinical endpoints - Cone beam computed tomography; Objective clinical endpoints - VAS; Objective clinical endpoints - WOMAC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov